Patroneva AL - Search Results

1

Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system.

Preskorn SH, Nichols AI, Paul J, Patroneva AL, Helzner EC, Guico-Pabia CJ. Preskorn SH, et al. Among authors: patroneva al. J Psychiatr Pract. 2008 Nov;14(6):368-78. doi: 10.1097/01.pra.0000341891.43501.6b. J Psychiatr Pract. 2008. PMID: 19057238 Review.

2

Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.

Preskorn S, Patroneva A, Silman H, Jiang Q, Isler JA, Burczynski ME, Ahmed S, Paul J, Nichols AI. Preskorn S, et al. J Clin Psychopharmacol. 2009 Feb;29(1):39-43. doi: 10.1097/JCP.0b013e318192e4c1. J Clin Psychopharmacol. 2009. PMID: 19142106 Clinical Trial.

3

An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects.

Patroneva A, Connolly SM, Fatato P, Pedersen R, Jiang Q, Paul J, Guico-Pabia C, Isler JA, Burczynski ME, Nichols AI. Patroneva A, et al. Drug Metab Dispos. 2008 Dec;36(12):2484-91. doi: 10.1124/dmd.108.021527. Epub 2008 Sep 22. Drug Metab Dispos. 2008. PMID: 18809731 Clinical Trial.

4

The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adults.

Nichols AI, Fatato P, Shenouda M, Paul J, Isler JA, Pedersen RD, Jiang Q, Ahmed S, Patroneva A. Nichols AI, et al. J Clin Pharmacol. 2009 Feb;49(2):219-28. doi: 10.1177/0091270008326716. Epub 2008 Nov 11. J Clin Pharmacol. 2009. PMID: 19001559 Clinical Trial.

5

Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.

Lobello KW, Preskorn SH, Guico-Pabia CJ, Jiang Q, Paul J, Nichols AI, Patroneva A, Ninan PT. Lobello KW, et al. J Clin Psychiatry. 2010 Nov;71(11):1482-7. doi: 10.4088/JCP.08m04773blu. Epub 2010 Apr 6. J Clin Psychiatry. 2010. PMID: 20441720 Clinical Trial.

6

Effect of an ATP-sensitive potassium channel opener in subjects with overactive bladder: a randomized, double-blind, placebo-controlled study (ZD0947IL/0004).

Chapple CR, Patroneva A, Raines SR. Chapple CR, et al. Eur Urol. 2006 May;49(5):879-86. doi: 10.1016/j.eururo.2006.01.037. Epub 2006 Feb 24. Eur Urol. 2006. PMID: 16517051 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6 results

Search Page